Key Insights - The report indicates that the intersection of financial reports and macroeconomic improvement is evident, with April's overall industry prosperity index continuing to decline but at a slower rate [1] - The sectors showing potential for growth include TMT components such as storage chains, communication equipment, computer devices, and software development [1] - Certain manufacturing industries are reportedly surpassing capacity cycle inflection points, with signs of demand stabilization, particularly in military electronics, aviation equipment, general machinery, agricultural machinery, batteries, wind power equipment, and photovoltaic equipment [1] - Consumer staples and discretionary goods are experiencing a recovery in prosperity rates, including dairy products, dining-seasoning products, and personal care items [1] - Price increases or stabilization is noted in some cyclical goods, including precious metals, rare earths, steel, and cement [1] Company-Specific Insights - Tencent Holdings reported a 13% year-on-year revenue growth in Q1, exceeding consensus expectations by 2.5%, with value-added services, advertising, and fintech revenues growing by 17%, 20%, and 5% respectively [2] - The adjusted net profit attributable to shareholders increased by 22% year-on-year, also surpassing expectations by 2.5% [2] - Capital expenditures for Q1 reached 27.5 billion, aligning with the company's capex progress, which is expected to account for 11-13% of revenue in 2025 [2] - The long-term outlook for Tencent's gaming operations remains positive, with the WeChat mini-store expected to drive growth in commissions and advertising [2] Additional Company Insights - SEA's Q1 revenue was reported at $4.84 billion, reflecting a year-on-year increase of 29.6%, slightly below the consensus expectation of 31.2% due to deferred gaming revenue and lower-than-expected e-commerce revenue [5] - Adjusted EBITDA for SEA was $0.95 billion, outperforming the consensus estimate of $0.7 billion [5] - Management maintains a 20% growth guidance for e-commerce GMV in 2025, with expectations for double-digit growth in active users and bookings in the gaming segment [5]

Core Viewpoint - The company is planning to expand its production and research capabilities by investing in a new research and production base in Guangzhou, which is part of its C2M supply chain strategy aimed at increasing market share and competitive advantage [4][6][7]. Group 1: Meeting Information - The first extraordinary general meeting of shareholders for 2025 will be held on May 22, 2025, at 15:30 in Guangzhou [3]. - The meeting will include both on-site and online voting options for shareholders [3][4]. - The agenda includes signing an output input supervision agreement and discussing external investments [4][7]. Group 2: Investment Details - The company has acquired a land parcel (ZSCB-E3-4) of approximately 31,585 square meters for the new research and production base, which will be adjacent to another site (ZSCB-E3-3) [5][6]. - The planned investment for the new base is 600 million RMB, focusing on various functions including office, research, production, and employee facilities [6][7]. - The investment does not constitute a related party transaction or a significant asset restructuring as defined by regulations [7].

Core Insights - JD's Q1 2025 revenue reached 301.1 billion yuan, a year-on-year increase of 15.8%, marking the highest quarterly growth rate in three years, with service revenue at 58.8 billion yuan, up 14.0% year-on-year [2][10] - Non-GAAP net profit attributable to ordinary shareholders was 12.8 billion yuan, exceeding expectations by 43.4% [2][10] - The retail revenue of JD grew by 16.3% year-on-year to 263.8 billion yuan, driven by strong user growth and supply chain optimization [2][10] Revenue and Profitability - The group achieved a gross margin of 15.9%, an increase of 0.6 percentage points year-on-year, and a fulfillment gross margin of 9.3%, up 0.5 percentage points year-on-year [3][10] - JD's retail operating profit margin improved by 0.8 percentage points to 4.9% [3][10] - The company continues to enhance its operational efficiency through its supply chain infrastructure and smart integration of business ecosystems [3][10] Business Development - JD's food delivery service surpassed 10 million daily orders as of April 22, 2025, indicating significant progress in this segment [3][10] - The company has repurchased 1.5 billion USD worth of shares, amounting to approximately 2.8% of its outstanding shares as of December 31, 2024 [3][10] - The expansion of the platform into new markets, including Hong Kong and international regions, is ongoing, with a focus on maintaining high growth rates in various product categories [10] Policy and Market Environment - The April Politburo meeting emphasized stabilizing employment and the economy, with a focus on expanding domestic demand and promoting consumption [4][11] - The government is expected to introduce flexible policies to address uncertainties in tariffs and enhance financial support for various sectors [11] - The focus on long-term structural reforms and support for consumer spending is anticipated to drive economic growth in the coming quarters [11]

Core Viewpoint - Runben Co., Ltd. (603193.SH) reported strong financial performance for 2024 and Q1 2025, with significant revenue and profit growth, but faces concerns regarding its marketing-heavy strategy and rising inventory levels [1][4][14]. Financial Performance - In 2024, the company achieved revenue of 1.318 billion yuan, a year-on-year increase of 27.61%, and a net profit of 300 million yuan, up 32.8% [1][2]. - For Q1 2025, revenue reached 240 million yuan, reflecting a 44% year-on-year growth, while net profit was 44.2 million yuan, a 24.6% increase [1][2]. Revenue Breakdown - The revenue from the mosquito repellent series was 439 million yuan, up 35.39%, accounting for 33.3% of total revenue; the baby care series generated 690 million yuan, a 32.42% increase, making up 52.4%; and the essential oil series brought in 158 million yuan, growing by 7.88%, representing 11.9% [4][9]. Marketing and R&D Expenditure - The company has spent significantly on marketing, with promotional expenses totaling nearly 6 billion yuan from 2020 to 2023, while R&D expenses were only 71 million yuan during the same period [14][15]. - In 2024, sales expenses reached 380 million yuan, a 41.25% increase, with 321 million yuan allocated for promotional activities [14][15]. Inventory Concerns - As of the end of 2024, the company's inventory value was 119 million yuan, a 28% increase year-on-year, marking the highest level since 2020 [12][10]. - The production volumes exceeded sales volumes across all product lines, leading to inventory accumulation, with mosquito repellent, baby care, and essential oil series having respective unsold stock increases of 14.25%, 12.93%, and 39.82% [12][13]. Future Plans - The company plans to invest 6 billion yuan in a new R&D base in Guangzhou, aimed at enhancing its production and research capabilities in personal care, cosmetics, and medical devices [18][19].

Summary of Conference Call Records Industry Overview - The beauty and personal care industry has shown a recovery in Q1, with domestic brands gaining market share, particularly through category and channel breakthroughs. Companies like Luoyuchen and Jiahua have improved margins through organizational adjustments and product innovation [1][4] - The personal care market is experiencing stable growth with a trend towards premiumization. Domestic brands are gaining an advantage in emerging channels like Douyin, with strong revenue growth and consumer recognition of their market share increase [1][5] - Live-streaming e-commerce has provided domestic beauty and personal care brands with opportunities to effectively reach young consumers, enhancing brand awareness and sales channels [1][6] Key Companies and Performance - **Mao Geping**: Achieved significant growth above industry averages, expected to maintain a 30% compound annual growth rate (CAGR) over the next three years due to high-end offline channels and effective online marketing [1][9] - **Ruo Yuchen**: Experienced rapid sales growth through product design and marketing innovation, particularly in the fragrance laundry liquid and health products sectors, with a sales target of 1 billion yuan for 2025 [1][9] - **Baiya and Dengkang**: Both companies have shown good revenue growth, with Baiya leveraging live-streaming e-commerce for expansion and Dengkang focusing on high-end products through targeted marketing on platforms like Douyin [1][10][11] Market Trends and Consumer Behavior - The demand for personal care products is stable but has shown a consistent price increase trend, driven by inflation and a shift towards health and natural product preferences among consumers [1][5] - The beauty industry is characterized by a long-term growth potential, with domestic brands continuing to gain market share. Current valuations have not yet returned to pre-2021 levels, indicating potential for valuation improvement [1][14] Future Growth Potential - The sanitary napkin market has reached a certain ceiling in domestic sales, but there is still room for growth in absorbent products like diapers and adult care items, as well as potential expansion into overseas markets [1][17] - The toothpaste market is also large, with opportunities for growth in related categories such as toothbrushes and mouthwash, indicating a robust growth outlook for the oral care sector [1][18] - The cotton soft towel market, as a new product category, has significant market potential due to its higher price point compared to traditional paper products, with companies like Weijian Medical expanding their product lines to enhance brand presence [1][19] Valuation Insights - Most personal care brands have not yet experienced the valuation premiums seen in 2021, with current valuations aligning with growth rates. However, as domestic brands continue to validate their growth, there is potential for increased valuation premiums in the future [1][20][21] - In the Hong Kong market, companies like Shangmei have a valuation of approximately 24 times earnings, while in the A-share market, Pulaoya's valuation is around 20 times, both indicating investment attractiveness [1][15]

Investment Rating - The report indicates a positive outlook for the textile and apparel industry, with a focus on potential recovery in manufacturing and consumer demand during the upcoming 618 shopping festival [3]. Core Insights - Tariff expectations have eased, with indications from U.S. Treasury Secretary that there is no intention to decouple from China in textiles and related goods, leading to a significant reduction in tariff-related anxiety [3]. - The manufacturing sector is expected to stabilize, with leading manufacturers showing strong resilience and potential for market share growth, particularly companies like Zhejiang Ziran, Kairun, and Huali Group [3]. - The upcoming 618 shopping festival is anticipated to boost domestic consumption, particularly benefiting beauty and personal care brands, as well as discretionary consumer goods [3]. Industry Data Tracking Retail Data - In March, the total retail sales of consumer goods grew by 5.9% year-on-year, with clothing and cosmetics showing growth rates of 3.6% and 1.1%, respectively [17][18]. Raw Material Prices - The Cotlook A index for cotton increased by 0.9% to 13,899, while the Chinese cotton price index decreased by 0.4% to 14,122 [19]. - Polyester filament prices saw increases, with POY, FDY, and DTY rising by 4.0%, 3.1%, and 2.4% respectively [19]. Export Data - Vietnam's textile and apparel exports rose by 14.77% year-on-year in March, with footwear exports increasing by 15.77% [25]. Investment Recommendations - Focus on companies in high-growth sectors with strong fundamentals, such as Anta Sports and 361°, and those with business adjustments leading to high elasticity, like Hailan Home and Semir Apparel [6]. - Retail sector companies like Steady Medical and Dekang Oral are highlighted for their potential dual benefits from consumption boosts and valuation adjustments [6].

2025 年 05 月 12 日 行业周报 看好/维持 纺织服装 纺织服装 纺服&零售周报:制造端有望企稳回升，关注 618 大促催化(2025. 5.5-5.11) ◼ 走势比较 (30%) (20%) (10%) 0% 10% 20% 24/5/13 24/7/24 24/10/4 24/12/15 25/2/25 25/5/8 纺织服装 沪深300 相关研究报告 <<纺服&零售周报：美护品牌 Q1 表现 亮眼，个护景气度向上(2025.4. 28- 5.4)>>--2025-05-06 <<稳健医疗 24 年报及 25Q1 财报点 评：消费品业务加速成长，核心品类 增速亮眼>>--2025-04-29 <<健盛集团 24 年财报点评：业绩符 合预期，期待无缝利润弹性释放>>-- 2025-04-28 证券分析师：郭彬 电话： E-MAIL：guobin@tpyzq.com 分析师登记编号：S1190519090001 报告摘要 本周核心观点：1）关税预期缓和：根据商务部新闻发布，5 月 10 日 上午中美经贸高层会谈在瑞士日内瓦开始举行，中共中央政治局委员、国 务院副总理何立峰作为中美经贸中方牵头人。5 ...

面对复杂多变的外部环境，稳健医疗（300888）凭借多年的深耕细作与不断创新，于2024年收获了亮眼 的成绩，实现业绩与ESG表现的双轮驱动式发展。步入2025年，公司发展势头更为迅猛，第一季度的营 收和净利润均实现大幅增长，展现出强大的市场竞争力。其在医疗和消费品两大板块的布局持续优化， 产品创新与市场拓展协同推进，在行业内树立起独特的竞争优势，为全年的稳健发展奠定了坚实基础。 一季度营收创历史新高，机构看好公司今年增长潜力 医用耗材业务去年实现营收39.1亿元，同比增加1.1%，剔除感染防护产品后，在去年第一季度感染防护 产品带来的高基数的情况下，全年同比仍然保持了正增长。公司扣非后归母净利润大幅增长主要因上年 同期商誉减值、感染防护产品及相关设备损失较大。 进入2025年一季度，公司延续良好发展态势。公告显示，公司一季度实现营收26.05亿元，同比增长 36.47%，营收创上市以来同期新高；归母净利润2.49亿元，同比增长36.26%；扣非后归母净利润2.34亿 元，同比增长62.46%，增速创上市以来同期新高。其中，医疗板块营收12.5亿元，同比增长46.3%，得 益于手术室耗材、高端敷料和健康个护品 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [3] Core Views - The company reported strong performance in Q1 2025, with a net profit increase driven by robust brand momentum in the consumer goods segment [7] - Revenue for 2024 reached 8.98 billion yuan, a year-on-year increase of 9.7%, while net profit was 700 million yuan, up 19.8% [7] - Q1 2025 revenue was 2.61 billion yuan, reflecting a 36.5% year-on-year growth, with net profit at 250 million yuan, up 36.3% [7] - The company plans to distribute a cash dividend of 0.25 yuan per share, alongside a mid-term dividend of 0.4 yuan per share, resulting in an annual dividend payout ratio of 54.4% [7] - The profit forecasts for 2025-2027 have been adjusted upwards, with expected net profits of 1.07 billion, 1.22 billion, and 1.41 billion yuan respectively [7] Summary by Sections Medical Consumables - In 2024, the medical consumables segment generated revenue of 3.91 billion yuan, a 1.1% year-on-year increase, while Q1 2025 revenue was 1.25 billion yuan, up 46.3% [8] - Key product categories such as high-end wound dressings and surgical consumables saw significant growth, with year-on-year increases of 31.2% and 48.8% respectively in 2024 [8] - The overseas channel revenue for 2024 and Q1 2025 was 2.13 billion and 700 million yuan, showing year-on-year growth of 37.7% and 84.1% respectively [8] Consumer Goods - The consumer goods segment achieved revenue of 4.99 billion yuan in 2024, a 17.1% year-on-year increase, with Q1 2025 revenue at 1.34 billion yuan, up 28.8% [9] - Specific product lines such as cotton soft towels and sanitary napkins experienced substantial growth, with Q1 2025 revenues increasing by 38.6% and 73.5% respectively [9] - Online sales channels contributed significantly, with 3.07 billion yuan in revenue for 2024 and 800 million yuan in Q1 2025, including a nearly 109% year-on-year growth in the Douyin channel for 2024 [9] Financial Performance - The gross profit margin for 2024 and Q1 2025 was 47.3% and 48.5%, with a slight year-on-year decrease of 1.7% and an increase of 0.8 percentage points respectively [10] - The net profit margin for 2024 was 7.8%, while Q1 2025 saw a slight decrease to 9.5% [10] - The inventory balance at the end of Q1 2025 was 1.96 billion yuan, a 34.1% increase, influenced by the acquisition of GRI [10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [3] Core Views - The company reported strong growth in net profit for Q1 2025, with a revenue increase of 36.5% year-on-year, reaching 2.5 billion yuan in net profit, up 36.3% [7] - The company plans to distribute a cash dividend of 0.25 yuan per share, along with a mid-term dividend of 0.4 yuan per share, resulting in an annual dividend payout ratio of 54.4% [7] - The forecast for net profit for 2025-2027 has been adjusted upwards, with expected figures of 10.7 billion yuan, 12.2 billion yuan, and 14.1 billion yuan respectively [7] Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 8.98 billion yuan, a year-on-year increase of 9.7%, and a net profit of 700 million yuan, up 19.8% [7] - For Q1 2025, the revenue was 2.61 billion yuan, reflecting a 36.5% increase, and the net profit was 250 million yuan, up 36.3% [7] Medical Supplies Business - The medical supplies segment generated 3.91 billion yuan in revenue for 2024, a 1.1% increase year-on-year, and 1.25 billion yuan in Q1 2025, a 46.3% increase [8] - Key product categories such as high-end wound dressings and surgical supplies saw significant growth, with increases of 31.2% and 48.8% respectively in 2024 [8] Consumer Products Business - The consumer products segment reported a revenue of 4.99 billion yuan in 2024, a 17.1% increase, and 1.34 billion yuan in Q1 2025, a 28.8% increase [9] - The brand "全棉时代" (All Cotton Era) continues to gain market traction, with notable growth in categories like wet and dry cotton towels, which saw a 38.6% increase in Q1 2025 [9] Profitability and Valuation - The gross margin for 2024 was 47.3%, with a slight increase to 48.5% in Q1 2025, while the net profit margin was 7.8% for 2024 and 9.5% for Q1 2025 [10] - The company’s P/E ratios for 2025-2027 are projected to be 28.5, 24.8, and 21.6 respectively, indicating a favorable valuation outlook [11]